Skip to main content

Table 2 Clinical data of steroid population

From: Impact of long-term steroid therapy on epicardial and pericardial fat deposition: a cardiac MRI study

Variable

Low-dose steroid group

High-dose steroid group

p

n

25

36

–

Age (years ± SD)

52 ± 19

55 ± 14

0.60

Female

18 (72.0)

25 (69.4)

–

BMI, kg/m2

25 ± 5

28 ± 6

<0.05

LVEF,  %

62 [61–71]

62 [56–65]

0.19

LVEDV, ml

120 [100–136]

121 [108–137]

0.64

LVESV, ml

42 [30–56]

45 [37–57]

0.22

Epicardial fat, cm2

4.7 [2.1–7.5]

7.2 [4.2–11.1]

<0.01

Pericardial fat, cm2

8.3 [2.3–18.7]

18.6 [8.9–38.2]

<0.001

CAD

2/25 (8.0)

7/36 (19.4)

0.29

Arterial hypertension

11 (44.0)

22 (61.1)

0.09

Systolic blood pressure, mmHg

123 ± 16

128 ± 21

0.23

Diastolic blood pressure, mmHg

74 ± 9

73 ± 10

0.81

Diabetes

3 (12.0)

7 (19.4)

0.51

Hypercholesterolemia

2 (8.0)

8 (22.2)

0.18

Total cholesterol, mmol/l

5.2 ± 3.12

5.37 ± 1.19

0.64

LDL cholesterol, mmol/l

3.2 ± 1.11

3.25 ± 0.98

0.88

HDL cholesterol, mmol/l

1.48 ± 0.52

1.52 ± 0.48

0.77

Triglycerides, mmol/l

4.46 ± 3.28

4.53 ± 3.57

0.95

Smoker

5 (20.0)

7 (19.4)

1.00

Positive family history of CAD

12 (48.0)

15 (41.7)

0.79

Daily steroid dose at inclusion, mg

5.0 [3.8–7.5]

15 [10–28]

0.46

Metabolic syndrome

0

2 (5.5)

0.51

  1. Values are mean ± SD, median [IQR], n (%); abbreviations see Table 1